Psychiatric Support

In addition to substance abuse/dependency, the vast majority of DSYTC clients also suffer from at least one mental health condition. Recognizing this and consistent with established best practices, the DSYTC aims to provide an integrated treatment approach which appropriately identifies and addresses concurrent mental health issues. As such, psychiatric consultation, assessment and treatment (e.g., pharmacotherapy) is available to live-in and continuing care clients.

Psychiatric services at the DSYTC are provided in partnership with Dr. Robert Milin, MD, FRCPC, DABPN.

Dr. Milin has completed combined fellowships in Child and Adolescent, and Addiction Psychiatry. He currently holds the position of Head of the Division of Addiction & Mental Health and Associate Professor, Department of Psychiatry, University of Ottawa.

As a clinician he is the Director of the Adolescent Day Treatment Unit, Youth Psychiatry Program, Royal Ottawa Mental Health Centre and was the Founding Clinical Director of the Youth Program. He also serves as the Consulting and Advisory Psychiatrist to the Dave Smith Youth Treatment Centre, a provincial centre for live-in youth addiction treatment. 

Dr. Milin is a Clinical Scientist with the University of Ottawa, Institute of Mental Health Research and maintains an active research profile. He has given over 100 peer-reviewed and invited presentations at various international, national and university forums.

Dr. Milin has been accorded numerous awards and recognitions over his career. In 2011, he received the honour of being named a “Master Clinician” by the American Academy of Child and Adolescent Psychiatry in recognition for his outstanding work in the field of child and adolescent psychiatry. Amongst various national and international professional academy duties, he serves as a member of the Board of Directors of the American Academy of Addiction Psychiatry.

Dr. Milin is a well-recognized clinician and researcher with content expertise in the fields of adolescent substance use disorders and early onset major psychiatric disorders in youth.